The great medicines scandal: Next steps?

BMJ 2006; 333 doi: 10.1136/bmj.333.7557.44-b (Published 29 June 2006)
Cite this as: BMJ 2006;333:44.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Warren A Kaplan (wak@bu.edu), assistant professor of international health
  1. Boston University School of Public Health, Boston, MA 02118, USA

    EDITOR—The recent World Health Organization-Health Action International, Europe report on disparities in price, availability, and affordability of medicines for chronic diseases is important work.1 This entire subject matter as it relates to medicines for chronic diseases deserves wider appreciation and understanding.

    It …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL